NCT05181852View on ClinicalTrials.gov

Study to Investigate the Pharmacodynamic Effects of IP2015 in Healthy Male Subjects Using the Intradermal Capsaicin Model

PHASE1UnknownINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 5, 2022

Primary Completion Date

May 30, 2022

Study Completion Date

July 1, 2022

Conditions
Pain
Interventions
DRUG

IP2015, dose 1

Active

DRUG

IP2015, dose 2

Active

DRUG

Placebo

Placebo

DRUG

Pregabalin

Comparator

Sponsors

Lead Sponsor

Initiator Pharma
All Listed Sponsors
lead

Initiator Pharma

INDUSTRY